• #78 – Jacob Trefethen on Global Health R&D

  • 2024/09/08
  • 再生時間: 2 時間 30 分
  • ポッドキャスト

#78 – Jacob Trefethen on Global Health R&D

  • サマリー

  • Jacob Trefethen oversees Open Philanthropy’s science and science policy programs. He was a Henry Fellow at Harvard University, and has a B.A. from the University of Cambridge.

    You can find links and a transcript at www.hearthisidea.com/episodes/trefethen

    In this episode we talked about open source the risks and benefits of open source AI models. We talk about:

    • Life-saving health technologies which probably won't exist in 5 years (without a concerted effort) — like a widely available TB vaccine, and bugs which stop malaria spreading
    • How R&D for neglected diseases works —
    • How much does the world spend on it?
    • How do drugs for neglected diseases go from design to distribution?
    • No-brainer policy ideas for speeding up global health R&D
    • Comparing health R&D to public health interventions (like bed nets)
    • Comparing the social returns to frontier (‘Progress Studies’) to global health R&D
    • Why is there no GiveWell-equivalent for global health R&D?
    • Won't AI do all the R&D for us soon?

    You can get in touch through our website or on Twitter. Consider leaving us an honest review wherever you're listening to this — it's the best free way to support the show. Thanks for listening!

    続きを読む 一部表示

あらすじ・解説

Jacob Trefethen oversees Open Philanthropy’s science and science policy programs. He was a Henry Fellow at Harvard University, and has a B.A. from the University of Cambridge.

You can find links and a transcript at www.hearthisidea.com/episodes/trefethen

In this episode we talked about open source the risks and benefits of open source AI models. We talk about:

  • Life-saving health technologies which probably won't exist in 5 years (without a concerted effort) — like a widely available TB vaccine, and bugs which stop malaria spreading
  • How R&D for neglected diseases works —
  • How much does the world spend on it?
  • How do drugs for neglected diseases go from design to distribution?
  • No-brainer policy ideas for speeding up global health R&D
  • Comparing health R&D to public health interventions (like bed nets)
  • Comparing the social returns to frontier (‘Progress Studies’) to global health R&D
  • Why is there no GiveWell-equivalent for global health R&D?
  • Won't AI do all the R&D for us soon?

You can get in touch through our website or on Twitter. Consider leaving us an honest review wherever you're listening to this — it's the best free way to support the show. Thanks for listening!

#78 – Jacob Trefethen on Global Health R&Dに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。